Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice—a new potential probiotic for appetite and body weight management
Open Access
- 7 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Obesity
- Vol. 44 (5), 1041-1051
- https://doi.org/10.1038/s41366-019-0515-9
Abstract
Background/objectives Based on the recent identification of E.coli heat shock protein ClpB as a mimetic of the anorexigenic α-melanocyte stimulating hormone (α-MSH), the objective of this study was to preclinically validate Hafnia alvei, a ClpB-producing commensal bacterium as a potential probiotic for appetite and body weight management in overweight and obesity. Methods The involvement of enterobacterial ClpB in the putative anti-obesity effects was studied using ClpB-deficient E.coli. A food-grade H. alvei HA4597 strain synthetizing the ClpB protein with an α-MSH-like motif was selected as a candidate probiotic to be tested in ob/ob and high-fat diet (HFD)-fed obese and overweight mice. The relevance of the enterobacterial ClpB gene to human obesity was studied by in silico analysis of fecal metagenomes of 569 healthy individuals from the “MetaHIT” database. Results Chronic per os administration of native but not ClpB-deficient E.coli strain reduced body weight gain (p < 0.05) and daily meal frequency (p < 0.001) in ob/ob mice. Oral gavage of H.alvei for 18 and 46 days in ob/ob and HFD-fed obese mice, respectively, was well tolerated, reduced body weight gain and fat mass in both obesity models (p < 0.05) and decreased food intake in hyperphagic ob/ob mice (p < 0.001). Elevated fat tissue levels of phosphorylated hormone-sensitive lipase were detected in H.alvei -treated ob/ob mice (p < 0.01). Enterobacterial ClpB gene richness was lower in obese vs. non-obese humans (p < 0.0001) and correlated negatively with BMI in genera of Enterobacter, Klebsiella and Hafnia. Conclusions H.alvei HA4597 strain reduces food intake, body weight and fat mass gain in hyperphagic and obese mice. These data combined with low enterobacterial ClpB gene abundance in the microbiota of obese humans provide the rationale for using H.alvei as a probiotic for appetite and body weight management in overweight and obesity.Keywords
This publication has 37 references indexed in Scilit:
- Dietary intervention impact on gut microbial gene richnessNature, 2013
- Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coliInternational Journal of Obesity, 2013
- Human gut microbiome viewed across age and geographyNature, 2012
- Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal ResponsesCell Metabolism, 2010
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneThe New England Journal of Medicine, 2003
- Study of Enterobacteriaceae throughout the manufacturing and ripening of hard goats' cheeseJournal of Applied Bacteriology, 1993
- Enterobacteriaceae, coliforms, faecal coliforms and salmonellas in raw ewes'milkJournal of Applied Bacteriology, 1987
- Inventaire de la flore bactérienne dominante des Camemberts fabriqués avec du lait cruLe Lait, 1983
- DISTRIBUTION OF AMINO ACID DECARBOXYLASES IN ENTEROBACTERIACEAE1Acta Pathologica Microbiologica Scandinavica, 1954